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Role of PI3k/Akt Pathway in the Cytoprotective Ef-
fects of Erythropoietin and Derivatives in Ischemic
Human Myotubes
Rebekah Yu, George Hamilton, Daryll Baker, Janice Tsui.
Department of Surgery, University College London, Lon-
don, United Kingdom
Objectives: Erythropoietin (Epo) has tissue-protec-
tive effects following ischemic injury, mediated through
the EpoR-cR heteroreceptor. Having previously shown
presence of the EpoR in human skeletal muscle, we now
aim to show the direct interaction of the EpoR with the
cR. Further, we wanted to determine the cytoprotec-
tive effects of Epo and an Epo-derivative (ARA-290) in a
human in vitro model of skeletal muscle and establish the
role of PI3K/Akt pathway in protecting cells from
apoptosis.
Methods: Gastrocnemius muscle biopsies were ob-
tained from patients with critical limb ischemia and
control samples were obtained from non-ischemic pa-
tients. Co-immunoprecipitation (Co-IP) was performed
to demonstrate heterodimerisation of EpoR with cR.
Human myoblasts were isolated to determine the cyto-
protective effects of Epo and ARA-290 pre-treatment on
myotubes subjected to simulated ischemia. Wortmannin
(PI3k inhibitor) was used to determine the role of PI3k/
Akt pathway in mediating cytoprotection. Western blot
analysis, using the pro-apoptotic marker cleaved
caspase-3 was performed and compared with levels of
Akt and phosphorylated-Akt, using western blot analysis.
Results: EpoR and cR has been demonstrated in
human skeletal muscle. Heterodimerisation of EpoR-cR
was confirmed by Co-IP. Epo and ARA-290 were able to
ameliorate the ischemia-induced apoptosis on isolated
human myotubes. Addition of wortmannin, to ARA-290
or Epo pre-treated cells, abolished the reduction in
apoptosis. Further, a reduction in apoptosis was associ-
ated with an increase in phosphorylated-Akt on western
blot analysis.
Conclusions: EpoR-cR heteroreceptor was demon-
strated in human skeletal muscle. ARA-290 attenuates
apoptosis in ischemic human myotubes suggesting a
potential role in tissue protection during skeletal muscle
injury. We propose that the PI3k/Akt signalling pathway
is involved in mediating this cytoprotection.
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Tracking the Migration of Porcine Mesenchymal Stem
Cells with the MRI Contrast Agent Ferex in an AAA
Model
Rami Tadros, Bhakti Rawal, Karen Briley-Saebo, David
O’Connor, Dan Han, Roger Hajjar, Zahi Fayad, Michael
Marin, Peter Faries. The Mount Sinai School of Medicine,
New York, NY
Objectives: Mesenchymal stem cells (MSC) are being
investigated in a porcine abdominal aortic aneurysm
(PAAA) model for their repair potential. This study uses
MSCs labeled with the MRI contrast agent Ferex to non-
invasively evaluate MSC migration in-vivo.
Methods: MSCs from six pigs were isolated from
bone marrow via Ficoll Paque separation and expanded
in culture. Using a Lentiviral vector, MSC from all six
pigs were labeled with green florescent protein (GFP).
MSCs from four of these pigs were labeled with Ferex
using Poly-L-Lysine, a cationic transfecting agent. These
cells were analyzed for Ferex uptake and viability. Pres-
ervation of the MSC phenotype was confirmed using
cytometry by detecting positive CD90 signals and nega-
tive CD45 and CD117. Transmission electron micros-
copy established that Ferex particles localized to lyso-
somes of labeled cells. MSCs were then injected into the
PAAA. In-vivo MRI was performed at intervals followed
by euthanasia and histologic analysis.
Results: Ferex labeled MSCs were visible at 4, 11,
and 15 days using MRI and the signal loss progressed at
each study interval representing cellular movement (Fig
1). MSC migration and localization were confirmed with
GNP visualization on fluorescence microscopy and im-
munohistochemistry. A correlation between in-vivo
MRI signals and iron deposition was clearly demon-
strated histologically using Perl’s staining.
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Conclusions: Ferex can be used as an in-vivo tracking
agent of MSCs in PAAA models.
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Vascular Endothelial Growth Factor-C Derived from
CD11b Positive Macrophages Induces Therapeutic
Improvements in a Murine Model of Hind Limb
Ischemia
Go Kuwahara1, Hitomi Nishinakamura2, Tadashi
Tashiro1, Shohta Kodama2. 1Department of Cardiovascu-
lar Surgery, Faculty of Medicine, Fukuoka University, Fu-
kuoka City, Japan; 2Department of Regenerative Medicine
& Transplantation, Faculty of Medicine, Fukuoka Univer-
sity, Fukuoka City, Japan
Objectives: Bone marrow cells(BMCs) that include
stem and progenitor cells are widely accepted to apply to
patients suffering with peripheral arterial disease(PAD) as a
therapeutic approach to induce neo- vascularization. How-
ever, the critical paracrine effects are still unclear to admin-
istrate BMCs. We focused macrophages that regulate
VEGF, especially in VEGF-C.
Methods: Male C57BL/6 mice were administered
intramuscular injections of PBS control, unselected BMCs,
CD11b, CD11b- cells from BMCs, and recombinant
VEGF-C to ischemic model of hind limb. As the evalua-
tions, perfusion was measured with a laser Doppler scan-
ning that were collected on days 0,1, 3, 7, 14, 21, and 28
including a functional assay such as catwalk in parallel.
Capillary density was determined by direct counting vessels
positive with Von Willebrand factor at individual time
points. Moreover, lymphangiogenesis was assessed as
LYVE-1 positive cells.
Results: Post-ischemic recovery of hind limb perfu-
sion was significantly improved in BMCs, CD11b and
VEGF-C group to compare with control group as the
result of laser Doppler scanning. In the functional assay,
VEGF-C group dramatically recovered compared to
control group. The capillary/myofiber ratio in the thigh
muscle was higher in BMCs and VEGF-C group than in
control group same as LYVE-1 positive cells. Further-
more, the expression of VEGF, VEGF-C, their receptors
of mRNA and Protein were involved predominately in
CD11b cells.
Conclusions: CD11b macrophages play the critical
role for angiogenesis and lymphangiogenesis in the murine
model of hind limb ischemia. Consequently, recombinant
VEGF-C accelerates the recovery and may be a promising
therapeutic strategy for PAD patients.
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Performance of a Nanocomposite Polymer Small Di-
ameter Bypass Graft in a Log-term Sheep Model
Mital Desai1, Maqsood Ahmed2, Achala de Mel2, Janice
Tsui1, Alexander M. Seifalian2, George Hamilton1.
1Royal Free Hampstead NHS Trust, London, United
Kingdom; 2University College London, London,
United Kingdom
Objectives: To evaluate in vivo performance of small
diameter grafts (5 mm) made from a compliant, thrombo-
resistant, bio-durable POSS-PCU polymer in a challenging
ovine model.
Methods: POSS-PCU grafts were implanted in 12
sheep as interposition grafts in left common carotid artery
(LCA) (GLP Regulations; all had daily 75 mg aspirin).
Duplex imaging was performed on days 1, 7, 14 and then
monthly. Comparison wasmade with 5mm ePTFE grafts as
control (n6 sheep) and in all animals with the unoperated
right common carotid artery (RCA). Flow rates and graft
compliance were measured in all target vessels/grafts. Pat-
ent grafts were explanted after 9months. Following explan-
tation, all grafts were assessed independently by histological
analysis.
Results: Animal 8 did not survive the anaesthetic and
grafts 1 and 9 thrombosed immediately; these two carot-
ids exhibited irreversible spasm during surgery. Animal 7
had tortuous LCA with gross diameter mismatch and
thrombosed on day 14. Graft 4 blocked on day 15 and
Graft 3 on day 59. Six grafts were patent for 9 months.
Patency rates were 67% at 9 months and 78% at 6 weeks.
The ePTFE grafts in comparison had all occluded by 1
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